The construction project of anti Xinguan drug production base of the group's Xiansheng pharmaceutical started

Release time:

2022-06-13

The construction project of anti Xinguan drug production base of the group's Xiansheng pharmaceutical started

On the morning of June 8, the construction project of the commercial production base of anti Xinguan drugs of Xiansheng Pharmaceutical Co., Ltd., which was contracted by the group company, held a commencement ceremony in Jiangbei new area, Nanjing. Ma Jinshan, vice president of the group company and head of Nanjing company, attended the event. The base focuses on the planning and production of anti novel coronavirus drugs, which are used for the prevention and treatment of close contact people who have been exposed to the positive test of neocoronavirus, and help the rapid formation of a three-dimensional prevention and control system in China that takes vaccines as prevention and oral administration as treatment, which provides a solid guarantee for the success of anti epidemic. It is an anti epidemic project that the group company participates in again outside the construction of vaccine workshops. The project was approved and filed in early May. At present, the pile foundation construction permit has been obtained, and the "four supplies and one leveling" on site is being promoted at full speed. It is planned to complete the capping of ssd8432 production workshop by the end of October this year, and strive to put into production by the end of the year. (Nanjing company)

Commencement of Qinghai Taifeng lithium battery material project undertaken by the group company

The group has won the qualification for independent evaluation of intermediate professional titles of Construction Engineering Series

Recommended news

2026-09-18

Benchmarking against global standards! The Jotun Zhangjiagang project has successfully passed the safety audit conducted by its Norwegian headquarters.

In mid-September, a foreign‑owned owner‑audit expert team from Jotun’s Norwegian headquarters conducted a three‑day, headquarter‑level specialized safety audit at the Jotun Zhangjiagang project site undertaken by the Group.

2026-09-18

The Roche (Shanghai) project of the Group has successfully achieved 2 million safe man-hours.

On September 17, the Roche (Shanghai) Biopharmaceutical Production Base project, undertaken by the Group, successfully reached the milestone of 2 million safe man-hours.

2026-09-18

The Group dispatched personnel to attend the training on building trustworthy quality teams in chemical engineering construction.

On September 16–17, the China Chemical Construction Enterprises Association held a training course on building “Quality‑Trusted Work Teams” in Chengdu, with representatives from the Group in attendance. The training featured a live lecture by Shi Jie, a senior expert of the Association.

2026-09-09

Good News Abounds | The Group Has Secured Multiple Emerging Industry Projects in Succession

In the golden autumn season, bountiful harvests abound, and new‑generation growth sectors showcase their strength. Since August, leveraging its deep-rooted expertise and core competencies in industrial installation, the Group has successively won bids for five key projects in emerging productivity fields, with a total contract value exceeding RMB 250 million, injecting robust momentum into its resilient year‑end performance.

2026-09-03

Two QC achievements of the Group have been awarded at the National Engineering Construction Quality Management Achievement Competition.

Recently, the China Construction Industry Association announced the results of the 2026 Engineering Construction Quality Management Team Achievement Competition. Two QC projects submitted by the Group—“Improving the First-Pass Acceptance Rate for One-Time Forming of Exterior Concrete Moldings” and “Enhancing the First-Pass Welding Acceptance Rate for Dissimilar Steels”—were awarded second and third prizes, respectively.

2026-09-01

The Group convened a special meeting to study and implement the spirit of the branch‑company representatives’ symposium.

On the afternoon of August 31, the Group convened a meeting of heads of regional companies and departmental offices in the fourth-floor conference room at its headquarters to deliberate on the implementation of the spirit of the symposium for branch‑office representatives held by the Group on August 30.